Bioinorganic Chemistry and Applications

Bioinorganic Chemistry and Applications / 2010 / Article
Special Issue

Special Issue in Honor of Professor Nick Hadjiliadis’ Retirement

View this Special Issue

Research Article | Open Access

Volume 2010 |Article ID 973742 | https://doi.org/10.1155/2010/973742

Christiana A. Mitsopoulou, Constantinos Dagas, "Synthesis, Characterization, DNA Binding, and Photocleavage Activity of Oxorhenium (V) Complexes with -Diimine and Quinoxaline Ligands", Bioinorganic Chemistry and Applications, vol. 2010, Article ID 973742, 9 pages, 2010. https://doi.org/10.1155/2010/973742

Synthesis, Characterization, DNA Binding, and Photocleavage Activity of Oxorhenium (V) Complexes with -Diimine and Quinoxaline Ligands

Academic Editor: Spyros Perlepes
Received11 Mar 2010
Accepted01 Apr 2010
Published08 Jun 2010

Abstract

The complex [ReOCl3pq] (1) (where pq = 2-(2′pyridyl)quinoxaline) has been synthesized and fully characterized by UV-Vis, FTIR, 1 and 2D NMR, and cyclic voltammetry (CV). The DNA-binding properties of the complex 1 as well as of the compounds [ReOCl3bpy] (2), [ReOCl3phen] (3), and pq (4) were investigated by UV-spectrophotometric (melting curves), CV (cyclic voltammetry), and viscosity measurements. Experimental data suggest that complex 1 intercalates into the DNA base pairs. Upon irradiation, complex 1 was found to promote the cleavage of plasmid pBR 322 DNA from supercoiled form I to nicked form II. The mechanism of the DNA cleavage by complex 1 was also investigated.

1. Introduction

For many years transition metal complexes have piqued curiosity owing to their efficient DNA binding and cleavage properties under physiological conditions [114]. It has been demonstrated that inorganic complexes can be used in footprinting studies, as sequence specific DNA binding agents, as diagnostic agents in medicinal applications, and for genomic research. Among different modes of DNA cleavage, oxidative cleavage of DNA upon irradiation with visible light is of main interest due to the potential applications of such compounds in photodynamic therapy of cancer [3, 15] and references therein.

On the other hand, coordination chemistry of rhenium has been extensively developed in recent years due, to a large extent, to the fact that its complexes with diimine ligands display long lifetimes and also short-lived rhenium isotopes hold promise as -emitters in radiotherapy [14, 16, 17]. The chemistry of oxorhenium complexes arouses particular interest among these compounds not only for their implication in various reactions of industrial and biological importance, including olefin epoxidation and catalysis by cytochrome P-450 [18, 19], but also for their lipophilic character and the oxidation states of rhenium that is Re(I) to Re (VI) [17].

In this context, the design, synthesis, and reactivity of novel rhenium oxocomplexes have become the aim of several laboratories, including ours. To the best of our knowledge, studies on oxorhenium (V) complexes incorporating planar aromatic ligands that could bind to DNA have not been studied before. Nevertheless, quinoxaline (pq) has recently received considerable attention [20, 21]. The structure of the quinoxaline ligand is recognized from a great number of natural compounds such as riboflavin and molybdopterines, and can be used as antibacterial, antiviral, anticancer, antihelmintic, and insecticidal agent [22]. In addition, it adopts a planar conformation when chelates to a metal ion [20, 23, 24]. This planar appendage provides a handle for intercalative binding to DNA, positioning the complex for enhanced reactivity toward DNA.

In this paper, we present the synthesis and characterization of the oxorhenium (V) complex, [ReOC pq] (1). In order to elucidate the reactivity of this compound, we have also synthesized the complexes [ReOC bpy] (2) and [ReOC phen] (3) and studied their intercalating abilities. The ligands ( pyridyl)quinoxaline (4), 2, bipyridine (5), and 1-10-phenanthroline (6) belong to quinoxaline or diimine class of organic compounds (Figure 1).

The interaction of these compounds with double stranded calf thymus DNA has been investigated using circular dichroism spectroscopy (CD), DNA thermal denaturation analysis (melting point), CV, and viscosity measurements. The photocleavage reaction on DNA has been monitored by agarose gel electrophoresis. Understanding the interactions between the compounds under study and DNA, and their ability to damage DNA with photoactivation by visible light would be the first step toward the development of rhenium-based drugs which might be useful in photobiological applications such as photodynamic therapy.

2. Experimental

2.1. Materials

2-( -pyridyl)quinoxaline [25, 26] and [ReOC (PP ] [27] were prepared by reported procedures. All reactions and manipulations were conducted under a pure argon atmosphere using standard Schlenk techniques. Ultra-pure Milli-Q water (18.2 mΩ) was used in all experiments. Reagent grade solvents were dried and distilled by usual methods and the solvents were stored over molecular sieves (4 ). The chemicals were purchased by Aldrich and used as received. Calf thymus DNA (CT DNA) and pBR322 supercoiled plasmid DNA (stored at: 2 C) were purchased from Sigma (St. Louis, MO).

2.2. Methods and Instrumentation

Microanalysis (C, H, N) was carried out with a Euro Vector EA 3000 analyser. FT-IR spectra in solution and in KBr pellets were recorded on a Nicolet Magna IR 560 spectrophotometer with a 1.0 c resolution. UV-Vis spectroscopy was recorded on a Varian Cary 300E spectrophotometer at using cuvettes of 1 cm path length. The  NMR spectra were obtained at room temperature using a Varian Unity Plus 300 MHz spectrometer. Samples were run in a 5 mm probe with deuterated solvents as internal lock and reference. The assignment of the  NMR spectra of the free ligands and of the complexes is based on 2D NMR experiments (1H–1H COSY). A Fisons VG Quattro instrument with a VG Biotech Electrospray source, having a hexapole lens was employed for ESI-MS analysis [28].

Photolysis experiments were carried out with a 1000 W Xenon lamp in an Oriel, model 68820, Universal Arc. Lamp source was selected with appropriate interference filter (Corning).

Cyclic voltammetric (CV) measurements were performed in a single compartment cell with a three electrode configuration on a Pine AFCBP1 (pine Instrument Company, Groove City, PA, USA). Glassy carbon was the working electrode, and the reference electrode was a saturated calomel electrode (SCE). A platinum wire was used as the counter electrode.

All the experiments involving interaction of the complexes with DNA were conducted in twice distilled phosphate buffer (Titrisol, 5 mM) and NaCl (4 mM) and adjusted to pH = 7.00 or 5.00 with hydrochloric acid. A solution of calf thymus DNA (CT-DNA) in the buffer gave a ratio of UV absorbance at 260 and 280 nm of ca. 1.8-1.9 : 1, indicating that the DNA was sufficiently free of protein [29]. The concentration of DNA in nucleotide phosphate was determined by UV absorbance at 260 nm after dilution. The extinction coefficient, was taken as 6600  [29]. Stock solutions were stored at C and used after no more than 4 d. Supercoiled plasmid pBR322 DNA was stored at 2 C and its concentration in base pairs was determined by UV absorbance at 260 nm after appropriate dilutions taking as 13 100  .

2.3. DNA Binding Studies

Thermal denaturation experiments were performed with a Varian Cary 300 spectrophotometer. Samples for Tm measurements were obtained by adding 100  L of a freshly prepared stock solution of rhenium compound, dissolved in the buffer (4 Mm NaCl, 0.096 M K P , 0.2 M N HP , pH 5.0 or 4 mM NaCl, 0.026 M K P , 0.041 M N HP , pH 7.0), to 1.00 mL of a calf thymus DNA solution (60  g/mL) and incubating at C for 24 hours. As the solubility of compound 1 is poor in net water, it was firstly dissolved in MeOH (in any case the ratio of MeOH : water is no higher than 5 : 95). Under these circumstances, complex 1 is stable for at least a period of five days. Absorbance versus temperature profiles of DNA were measured at 258 nm in the temperature range from to . Temperature was raised in 0. C increments, and DNA complex samples were allowed to equilibrate for 1 minute at each temperature. The melting temperature ( ) of DNA was determined as the middle point of the hyperchromic transition. To correct the absorbance spectrum of DNA from the contribution of each of the studied compounds, the buffer solution of the corresponding complex at the same concentration in the sample was used as a blank.

Viscosity measurements were carried out using a Schott Geräte AVS 310 viscometer maintained at a constant temperature at in a thermostatic bath. DNA samples with approximately 200 base pairs in average length were prepared by sonication in order to minimize complexities arising from DNA flexibility. Flow time was measured with a digital stopwatch, while each sample was measured three times, and an average flow time was calculated. Data are presented as ( versus , where r = [DNA]/[complex 1], is the viscosity of DNA in the presence of complex, and is the relative viscosity of DNA alone. The relative viscosity of DNA in the presence and absence of the metal complex was calculated using the expression , where t is the observed flow time of the DNA solution and the flow rate of buffer alone. According to Cohen and Eisenberg [30] the relationship between the relative solution viscosity ( ) and contour length ) is given by the equation , where denotes the apparent molecular length in the absence of the metal complex.

2.4. DNA Photocleavage

For the gel electrophoresis experiment, pBR322 supercoiled plasmid DNA (0.1 lg) was treated with the Re (V) complexes in 50 mM Tris-acetate, 18 mM NaCl buffer (pH 7.2), and the solution was then irradiated at room temperature with a light 400 nm (100 W) inside a photoreactor. The samples were analyzed by electrophoresis for 1 hour at 100 V in Tris-acetate buffer containing 1% agarose gel. The gels were imaged with a BioSure UV-Transilluminator and photographed using a Picture Works Photo Enhancer v3.2 digital camera equipped with a 10  g/mL ethidium bromide filter.

2.5. Synthesis of Complexes

In this context, rhenium (V) metal complexes with bidentate (N,N) type ligands as 2-( pyridyl)quinoxaline (pq) 4, 2, -bipyridine (bpy) 5, and 1,10-phenanthroline (phen) 6, have been amply studied.

Ligands 5 and 6 were purchased by Aldrich and used as received, whereas ligand 4 was synthesized according to published procedures [26, 31].

2.5.1. Synthesis of [ReOC pq]

Potassium perhenate (KRe ) was used as a starting material. A solution of triphenylphosphine (PP ) (5.15 g, 18 mmol) in hot ethanol (29 mL) was added in a boiling mixture of potassium perhenate (1 g, 3.4 mmol), hydrochloric acid 37% (5.72 mL), and ethanol (5.72 mL). A yellow solid precipitates. The mixture was refluxed for 30 minutes and after cooling to room temperature, the yellow precipitate was filtered off, washed with ethanol, and dried in vacuo. By this procedure the precursor [ReOC (PP ] was obtained. The ligand pq was added in a solution of [ReOC (PP ] in dry methanol (20 mL) under stirring, and the mixture was heated to continuous reflux for 24 hours at 5 C. After cooling to room temperature, the resultant dark purple precipitate was filtered off, washed with diethylether, and dried in vacuo.

Yield: 57%. (0.732 g)  NMR (300 MHz; C OD; s, singlet; d, doublet; t, triplet; m, multiplet): 9.73(s, 1H, ), 8.15, 8.25(mt, 2H, ), 7.92(mt, 2H, ), 7.48(d, 1H, ,  =  ), 8.08(mt, 1H, ), 8.91(mt, 1H, ), 8.65(d, 1H, ,  =  ). Absorption spectrum:  =  (  =  ),  =  (  =  ). FT-IR spectrum: 939(vs) (νRe=O), 1630(m,br), 1580(w) and 1420(m) (νC–N) and (νC=C). Anal. Calcd for ReOC pq: C 30.27; H 1.76; N 8.15; Cl 20.62; O 3.10. Found: C 30.97; H 1.74; N 8.19%. ES-MS (CH3CN: m/z (M— ) 516.8.

2.5.2. Synthesis of [ReOC bpy]

This compound was prepared by refluxing [ReOC (PP ] (0.83 g, 1 mmol) and bpy (1.3 mmol) in methanol (50 mL) for 6 hours using the procedure employed for 1. A red microcrystalline material was isolated.

Yield: 88%. (0.554 g)  NMR (300 MHz; C COC ; s, singlet; d, doublet; t, triplet; m, multiplet): 9.09(d, 2H, , ), 8.03(d, 2H, , ), 7.84(t, 2H, ), 7.37(t, 2H, ). Absorption spectrum: (MeOH) = 480.8 nm ( ), (MeOH) = 750.2 nm ( ), FT-IR spectrum: 988  (νRe=O), 1640–1570  (νC=C, (bpy)). Anal. Calcd for ReOC bpy: C 25.84; H 1.74; N 6.03; Cl 22.89; O 3.44. Found: C 26.03; H 1.79; N 6.19%. ES-MS (C CN: m/z (M— ) 465.9.

2.5.3. Synthesis of [ReOC phen]

This compound was prepared by refluxing ReOC (PP (0.83 g, 1 mmol) and phen (0.26 g 1.3 mmol) in methanol (50 mL) for 48 hours using the procedure employed for 1. A dark red microcrystalline material was isolated.

Yield: 84%. (0.843 g) 1H NMR (300 MHz; CD3COCD3; s, singlet; d, doublet; t, triplet; m, multiplet): 8.90(d, 2H, ), 8.37(d, 2H, ), 7.40(s, ), 7.69(mt, ). Absorption spectrum: (MeOH) = 459.6 nm ( = 3200 M-1 cm-1), (MeOH) = 739.6 nm ( = 1100 M-1 cm-1), FT-IR spectrum: 985 cm-1 (νRe=O), 1628(w), 1605(m), 1575(w), 1520(m) cm-1 (νCN and νC=C, (phen)). Anal. Calcd for ReOCl3phen: C 29.37; H 2.05; N 5.71; Cl 21.67; O 3.26. Found: C 30.03; H 2.17; N 5.99%. ES-MS (CH3CN: m/z (M—Cl+) 489.8.

3. Results and Discussion

3.1. Synthesis

2-( pyridyl)quinoxaline (pq) is produced via an unusual condensation reaction from 2-acetylpyridine and 1,2-diaminobenzene and has been extensively studied because of its rich coordination chemistry. 2-( pyridyl)quinoxaline belongs to the general class of quinoxalines which are natural products, used as antibiotics and form polymers with peculiar magnetic and electric properties. Their significant redox chemistry and photochemistry are responsible for many considerable intra and intermolecular electron transfer organic and biochemical processes. The aforementioned ligand as well as bpy and phen has been coordinated to the oxorhenium moiety.

The most significant m/z peaks in ESI-mass spectra of complexes 13 are given in the Synthesis Section. They correspond to the molecular weight of the complex increased by one unit for complex 1, so that [M- ] form is attributed, implying that a proton has been attached on the N(3) atom of the quinoxaline ring. On the other hand, complexes 2 and 3 eliminate a -Cl atom providing the form [M-Cl . Surprisingly, we were not able to isolate crystalline complex from the oxorhenium-quinoxaline system in which only the typical chelate bonding of an -diimine ring is present. In fact, up to now only few oxorhenium- -diimine crystal structures have appeared in the literature though it is well-known that radioactive e and e are important diagnostic nuclear agents. Actually, the crystal structure of the ReOC phen was recently reported [32]. According to the data presented therein, the rhenium atom is in a distorted octahedral environment with the three chloride ligands arranged in a meridional fashion and the oxo ligand trans to the nitrogen atom of the phenanthroline. As the complexes under study 1 and 2 are isomorphous to 3, we expect to adopt similar geometries.

3.2. Characterization of [ReOC ( -diimine)] Complexes
3.2.1. Infrared Data

The IR spectra of 1, 2, and 3 exhibit very strong bands at 939, 988, and 985  , respectively, assignable to the ν(Re=O) mode. These values compare well with those reported for rhenium (V) complexes containing a chelating ligand in their coordination sphere [32]. The characteristic bands corresponding to the ν(CN) and ν(C=C) modes of the quinoxaline and diimine ligand appear in the range 1680–1420  in the IR spectra of the complexes 13 [20, 25, 32].

3.2.2. NMR Spectroscopy

The oxorhenium complexes 13 give well-defined -NMR spectra, which permit unambiguous identification and assessment of purity. The proton chemical shifts are assigned with the aid of -COSY experiments (provided in Section 2).

It is worth to discuss the complexation of 2-( pyridyl)quinoxaline to the [ReOC (PP ] moiety since it entails two major changes: the first involves the configuration of 2- pq switching from the syn/cis- to the anti/trans-conformation, while the second is related to the withdrawal of its electron density by the metal. These changes are reflected on the NMR spectra of the complex. Figure 2 displays the 1H–1H COSY spectra of the free ligand L and of the complex, which are important for assigning of the 1D-NMR peaks.

The NMR spectrum of the coordinated ligand L differs from that of the free ligand (Figure 2) mainly due to the separation of and signals and to an overall downfield shift. The latter is due to the reducing electron charge of the protons after coordination of the ligand. The most downfield shifted peak remains the (s) [31]. The same switching from syn/cis- to the anti/trans-conformation is also observed in the spectrum due to the complexation of 2- -bipyridine ligand.

3.2.3. UV-Vis Spectroscopy

The electronic absorption spectra of [ReOCl3( -diimine)] in the area between 300 and 800 nm are shown in Table 1. The UV-Vis spectra of 13 exhibit few intense bands in the range of 570–200 nm and a weak absorption in the low range 730–750 nm. According to TD-DFT calculations [32], the longest wavelength experimental band of 1, 2, and 3 at 732, 750, and 739 nm, respectively, is attributed to the transition of d → d character. The broad MLCT absorption band appears at 571, 480, and 459 nm for complexes 1, 2, and 3, respectively. It originates from the orbitals to the orbitals [32] and it is blue shifted in less polar solvents (Table 1), indicating its charge transfer character. The higher energy absorption bands at UV region are attributed to ligand-ligand charge transfer transitions, namely, ( )Cl/( )O/( )diimine → (diimine), interligand transitions.


Complex versus SC nm nm
(V) (V)

[ReOCl3pq]
(1)
−0.52−0.70268.5 (4835)272.4 (4820)
571.0 (3330)581.2 (3520)
732.1 (1227)738.3 (1337)

[ReOCl3bpy]
(2)
−0.54−0.72295.3 (4315)294.1 (4330)
480.8 (3430)493.0 (3520)
750.2 (1450)753.0 (1480)

[ReOCl3phen]
(3)
−0.44−0.61270.6 (4580)268.3 (4350)
459.6 (3200)463.7 (3300)
739.6 (1100)745.0 (1150)

complexes were measured in 0.1 M TBAB -DMF; error in potential was 0.01 V; = 25 ± 0. C; scan rate = 100 m
C OH, [C] = 1  M
C COC , [C] = .
3.2.4. Electrochemical Behaviour of Complexes

The redox properties of the compounds 1–3 have been investigated by cyclic voltammetry, at a Pt electrode, usually in a 0.1 M TBAB -DMF solution at , and the measured redox potentials (in V versus SCE) are given in Table 1. Solutions were deoxygenated by purging with argon gas for 15 minutes prior to the measurements; during the measurements a stream of argon was passed over the solution. All the studied complexes exhibit (Table 1) a reduction wave which is usually followed, at the lowest potential, by a second one. These waves often correspond to single-electron reversible processes, being assigned to the and metal reductions. Previous studies have shown that the diimine ligand influences the reduction potential of the compounds. The oxidation for all three complexes occurs at very similar potentials. Both reduction potentials occur at negative potentials.

3.3. Biological Assays
3.3.1. Tm Measurements

The study of the melting curves of C.T.-DNA indicates that the interaction of DNA with the oxorhenium (V) complexes 1 and 2, leads to the stabilization of the double helix in proportion to the ratio - - (Table 2). The stabilization can be assumed by the raising of the which is finally observed in analogy with reaching at for 1 at and (Figure 3). In the presence of all three complexes (13) the thermal stabilization of CT-DNA is observed in the series . Moreover, the reduction of the final hyperchromicity and the decrease of the slope of melting curves (increase of the transition) provide a strong evidence of the interaction which leads to DNA helix stabilization [33]. “Premelting effects” of the double helix which could be caused by the binding of oxorhenium (V) complexes, probably via allosteric effects, are rather not taking place since they would result in DNA helix destabilization [34]. The reversibility measurements of the 1 and 3 binding to CT-DNA (cooling the samples and reheating them) showed completely super-imposable results onto the first heating scans. This suggests that the species present in the solution of 1 or 3, do not alone inhibit reannealing, associating irreversibly with the single strand which is similar to the results obtained for the free ligands. Although the complex [ReOC phen] is isostructural to the complexes [ReOC pq] and [ReOC bpy], it presents different behaviour when interacts with CT-DNA. In both buffered pH 7.0 and pH 5.0 solutions, at all ratios, the melting points of CT-DNA are almost the same with free CT-DNA. Identical results have been obtained when CT-DNA was treated with all free ligands under investigation. So we can conclude that there is almost no interaction between the complex [ReOC phen] and CT DNA. No observable changes are measured after irradiation.


C.T.-DNA R = 0.025R = 0.050R = 0.02 R = 0.050*
pH %hyp %hyp %hyp %hyp

[ReOC pq]7.080.1 18.081.8 13.077.9 12.079.1 12.0
(1)5.081.1 27.080.2 19.078.1 28.079.1 19.0

[ReOC bpy]7.076.9 44.076.9 39.075.4 45.075.1 36.0
(2)5.076.1 20.077.1 20.073.1 20.076.1 20.0

[ReOC phen]7.071.1 71.4 70.9 74.2
(4)5.073.1 73.3 73.1 73.1

lluminated samples. he melting point of the free CT-DNA is (pH 7.0) and (pH 5.0).
3.3.2. CV Studies

Electrochemical investigation of complex-DNA interactions can provide a useful complement to other methods and yield information about the mechanism of the interaction [23, 24, 35]. Figure 4 shows the cyclic voltammograms of the complex at the absence and the presence of DNA. A new irreversible redox peak appeared after the addition of CT DNA to complex 1, whereas the intensity of all peaks decreased significantly, suggesting the existence of an interaction between 1 and CT DNA. The observed decrease in current can be attributed both to the intercalation of complex 1 into the base pairs of DNA by the planar pq ligand [23, 24] and to an equilibrium mixture of free and DNA-bound complex to the electrode surface [35]. The experimental results are different for 2, where the current intensity of all the peaks decreased significantly after addition of CT DNA, and for 3 where no changes are observed in its cyclic voltammogram implying that complex 3 does not interact with DNA.

3.3.3. Viscosity Measurements

Optical photophysical probe provides necessary but not sufficient clues to support binding modes [24, 36], whereas hydrodynamic measurements that are sensitive to the length change are regarded as the most critical tests of a binding model in solution. Thus, to further clarify the interaction between 1 and DNA, we carried out viscosity measurements. Because the latter are ionic-strength-and-concentration dependent, we used a buffer of the same ionic strength for all measurements. Figure 5 shows the relative viscosity of DNA (100 lM) in the presence of varying amounts of complex 1. As we observe, the relative viscosity increases from 0.98 to 1.14 in relative low ratios, [complex]/[DNA], while it remains almost constant there after. The observed increase is at the same extent with the one observed when an intercalator is used, for example ethidium bromide—a well known intercalator, at the same ratios as complex 1 [24, 37]. This behaviour suggests that complex 1 intercalates to CT-DNA in accordance with the previous results.

3.3.4. DNA Photocleavage

The ability of complex 1 to cleave DNA upon irradiation was determined by agarose gel electrophoresis [38]. When circular plasmid DNA in the presence of an inorganic molecule is subject to electrophoresis, relatively fast migration will be observed for the intact supercoil form (Form I). If scission occurs on one strand (nicking), the supercoil will relax to generate a slower-moving open circular form (Form II). If both strands are cleaved, a linear form (Form III) that migrates between Forms I and II will be generated [38]. Figure 6 shows gel electrophoresis separation of pBR 322 DNA after incubation with complex 1 and irradiation by visible light ( ) for 1 hour. Complex 1 exhibited concentration-dependent single-strand cleavage of supercoiled Form I into nicked Form II. Control experiment (lane 0) suggests that untreated DNA does not show any cleavage upon irradiation, with increasing concentration of 1 (lanes 1–3); the amount of Form I of pBR322 DNA diminishes gradually, whereas that of Form II increases. Under comparable experimental conditions, complex 2 exhibits more effective DNA cleavage activity than complex 1. In order to identify the nature of the reactive species that are responsible for the photo-activated cleavage of the plasmid DNA, we further investigated the influence of different potentially inhibiting agents. In the case of complex 1 (Figure 7), studies with the single oxygen quencher histidine were carried out and the plasmid cleavage was inhibited (lane 2), which confirmed that the singlet oxygen was involved in the cleavage. At the same time, in the presence of different hydroxyl radical scavengers such as DMSO (lane 3), ethanol (lane 4) and sodium formate (lane 5), different degrees of inhibition in the photo-induced cleavage of the plasmid by complex 1 were also observed. This indicates that hydroxyl radical also plays a significant role in the photocleavage mechanism for 1, and the photoreduction of ReO complexes with concomitant hydroxide oxidation is an important step in the DNA cleavage reaction [38].

4. Conclusions

In summary, a new oxorhenium (V) complex namely, [ReOC pq] (1) together with its isostructural [ReOC bpy] (2) and [ReOC phen] (3) has been synthesized and characterized by elemental analyses, FT-IR, UV-Vis spectra, 1D, and 2D NMR, ESI-MS, and CV. The interactions between complexes 13 (as well as all a-diimine ligands) and calf thymus DNA have been investigated using UV-spectra, thermal denaturation measurements, CV, and viscosity measurements. Furthermore, the photocleavage of the plasmid pBR 322 DNA has been investigated by agarose gel electrophoresis. Remarkably, our results reveal that both complexes 1 and 2 bind to DNA by intercalation, with the planar diimine (pq or bpy) ligands stacked between the base pairs of the DNA. Complex 1 can efficiently cleave the plasmid pBR 322 DNA, upon irradiation whereas the reactive species responsible for its cleavage are the singlet oxygen and the hydroxyl radical. The thermal stabilization of DNA is reversed to the promoted photocleavage at physiological pH and temperature, indicating the differences in interactions between the base pairs of DNA and the ground or the excited state of the complexes. Similar observations have also been reported for rhenium (I) complexes [39, 40]. These complexes may be useful to probe nucleic acid structures and in the development of DNA agents. More detailed photophysical and biophysical studies designed to address the nature of the interactions of oxorhenium (V) are underway.

Acknowledgment

This work is financially supported by Special Research Account of NKUA. This paper is dedicated to Professor Dr. Nick Hadjiliadis with our best wishes in his retirement.

References

  1. G. M. Blackburn and M. J. Gait, Eds., Nucleic Acids in Chemistry and Biology, Oxford University Press, New York, NY, USA, 1996.
  2. H. T. Chifotides, K. M. Koshlap, L. M. Perez, and K. R. Dunbar, “Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(μ-carboxylato)dirhodium(II,II),” Journal of the American Chemical Society, vol. 125, no. 35, pp. 10714–10724, 2003. View at: Publisher Site | Google Scholar
  3. A. K. Patra, S. Roy, and A. R. Chakravarty, “Synthesis, crystal structures, DNA binding and cleavage activity of l-glutamine copper(II) complexes of heterocyclic bases,” Inorganica Chimica Acta, vol. 362, no. 5, pp. 1591–1599, 2009. View at: Publisher Site | Google Scholar
  4. M. L. Kopka, C. Yoon, D. Goodsell, P. Pjura, and R. E. Dickerson, “The molecular origin of DNA-drug specificity in netropsin and distamycin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 5, pp. 1376–1380, 1985. View at: Google Scholar
  5. M. Coll, C. A. Frederick, A. H. Wang, and A. Rich, “A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin.,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 23, pp. 8385–8389, 1987. View at: Google Scholar
  6. M. S. Searle and K. J. Embrey, “Sequence-specific interaction of Hoechst 33258 with the minor groove of an adenine-tract DNA duplex studied in solution by 1H NMR spectroscopy,” Nucleic Acids Research, vol. 18, no. 13, pp. 3753–3762, 1990. View at: Google Scholar
  7. W. Leupin, W. J. Chazin, S. Hyberts, W. A. Denny, and K. Wuthrich, “NMR studies of the complex between the decadeoxynucleotide d-(GCATTAATGC)2 and a minor-groove-binding drug,” Biochemistry, vol. 25, no. 20, pp. 5902–5910, 1986. View at: Google Scholar
  8. W. D. Wilson, C. R. Krishnamoorthy, Y.-H. Wang, and J. C. Smith, “Mechanism of intercalation: ion effects on the equilibrium and kinetic constants for the interaction of propidium and ethidium with DNA,” Biopolymers, vol. 24, no. 10, pp. 1941–1961, 1985. View at: Google Scholar
  9. C. A. Frederick, L. D. Williams, G. Ughetto et al., “Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin,” Biochemistry, vol. 29, no. 10, pp. 2538–2549, 1990. View at: Google Scholar
  10. A. H.-J. Wang, G. Ughetto, G. J. Quigley, and A. Rich, “Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-Å resolution,” Biochemistry, vol. 26, no. 4, pp. 1152–1163, 1987. View at: Google Scholar
  11. G. Sava, R. Gagliardi, A. Bergamo, E. Alessio, and G. Mestroni, “Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine,” Anticancer Research, vol. 19, no. 2, pp. 969–972, 1999. View at: Google Scholar
  12. J. L. Bear, C.-L. Yao, L.-M. Liu et al., “Synthesis, molecular structure, and electrochemical properties of two geometric isomers of tetrakis(µ-2-anilinopyridinato)dirhodium complexes,” Inorganic Chemistry, vol. 28, no. 7, pp. 1254–1262, 1989. View at: Google Scholar
  13. C. A. Crawford, E. F. Day, V. P. Saharan et al., “N7,O6 bridging 9-ethylguanine (9-EtGH) groups in dinuclear metal-metal bonded complexes with bond orders of one, two or four,” Chemical Communications, no. 10, pp. 1113–1114, 1996. View at: Google Scholar
  14. H. T. Chifotides, K. M. Koshlap, L. M. Perez, and K. R. Dunbar, “Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (μ-carboxylato)dirhodium(II,II),” Journal of the American Chemical Society, vol. 125, no. 35, pp. 10703–10713, 2003. View at: Publisher Site | Google Scholar
  15. S. Monro, J. Scott, A. Chouai et al., “Photobiological activity of Ru(ll) dyads based on (Pyren-1-yl)ethynyl derivatives of 1, 10-Phenanthroline,” Inorganic Chemistry, vol. 49, no. 6, pp. 2889–2900, 2010. View at: Publisher Site | Google Scholar
  16. C. Metcalfe, M. Webb, and J. A. Thomas, “A facile synthetic route to bimetallic ReI complexes containing two dppz DNA intercalating ligands,” Chemical Communications, no. 18, pp. 2026–2027, 2002. View at: Google Scholar
  17. T. W. Jackson, M. Kojima, and R. M. Lambrecht, “Rhenium diamino dithiol complexes. III lipophilic ligands for endotherapeutic radiopharmaceuticals,” Australian Journal of Chemistry, vol. 53, no. 11-12, pp. 983–987, 2000. View at: Google Scholar
  18. R. H. Holm, “Metal-centered oxygen atom transfer reactions,” Chemical Reviews, vol. 87, no. 6, pp. 1401–1449, 1987. View at: Google Scholar
  19. S. B. Seymore and S. N. Brown, “Charge effects on oxygen atom transfer,” Inorganic Chemistry, vol. 39, no. 2, pp. 325–332, 2000. View at: Publisher Site | Google Scholar
  20. I. Veroni, C. Makedonas, A. Rontoyianni, and C. A. Mitsopoulou, “An experimental and DFT computational study of a novel zerovalent tetracarbonyl tungsten complex of 2-(2-pyridyl)quinoxaline,” Journal of Organometallic Chemistry, vol. 691, no. 3, pp. 267–281, 2006. View at: Publisher Site | Google Scholar
  21. A. Garoufis, A. Koutsodimou, N. Katsaros, C.-A. Mitsopoulou, and N. Hadjiliadis, “Mixed ligand Ru(II) complexes with 2,2-bipyridine and 2-(2-pyridyl)quinoxaline,” Polyhedron, vol. 18, no. 3-4, pp. 361–369, 1998. View at: Google Scholar
  22. B. Zarranz, A. Jaso, I. Aldana, and A. Monge, “Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives,” Bioorganic and Medicinal Chemistry, vol. 12, no. 13, pp. 3711–3721, 2004. View at: Publisher Site | Google Scholar
  23. C. A. Mitsopoulou, C. E. Dagas, and C. Makedonas, “Synthesis, characterization, DFT studies and DNA binding of mixed platinum (II) complexes containing quinoxaline and 1,2-dithiolate ligands,” Journal of Inorganic Biochemistry, vol. 102, no. 1, pp. 77–86, 2008. View at: Publisher Site | Google Scholar
  24. C. A. Mitsopoulou, C. E. Dagas, and C. Makedonas, “Characterization and DNA interaction of the Pt(II)(pq)(bdt) complex: a theoretical and experimental research,” Inorganica Chimica Acta, vol. 361, no. 7, pp. 1973–1982, 2008. View at: Publisher Site | Google Scholar
  25. I. Veroni, C. A. Mitsopoulou, and F. J. Lahoz, “Isolation, X-ray structure and properties of an unusual pentacarbonyl(2,2-pyridyl-quinoxaline) tungsten complex,” Journal of Organometallic Chemistry, vol. 691, no. 26, pp. 5955–5963, 2006. View at: Google Scholar
  26. S. Kasselouri, A. Garoufis, A. Katehanakis, G. Kalkanis, S. P. Perlepes, and N. Hadjiliadis, “1:1 metal complexes of 2-(2-pyridyl)quinoxaline, a ligand unexpectedly formed by the reaction between 2-acetylpyridine and 1,2-phenylenediamine,” Inorganica Chimica Acta, vol. 207, no. 2, pp. 255–258, 1993. View at: Google Scholar
  27. J. Chatt and G. A. Rowe, “Complex compounds of tertiary phosphines and a tertiary arsine with rhenium (V), rhenium (III) and rhenium (II),” Dalton Transactions, pp. 4019–4024, 1962. View at: Google Scholar
  28. P. Falaras, C.-A. Mitsopoulou, D. Argyropoulos et al., “Synthesis, cyclic voltammetric and electrospray mass spectrometric studies of a series of tris-substituted 1,2-dithiolene complexes of tungsten and molybdenum,” Inorganic Chemistry, vol. 34, no. 18, pp. 4536–4542, 1995. View at: Google Scholar
  29. M. E. Reichmann, S. A. Rice, C. A. Thomas, and P. Doty, “A further examination of the molecular weight and size of desoxypentose nucleic acid,” Journal of the American Chemical Society, vol. 76, no. 11, pp. 3047–3053, 1954. View at: Google Scholar
  30. G. Cohen and H. Eisenberg, “Viscosity and sedimentation study of sonicated DNA-proflavine complexes,” Biopolymers, vol. 8, pp. 45–49, 1969. View at: Google Scholar
  31. I. Veroni, A. Rontoyianni, and C. A. Mitsopoulou, “Synthesis and characterization of a novel complex: Mo(CO) 4-[2-(2pyridyl)quinoxaline]. An insight based on experimental and theoretical data,” Dalton Transactions, no. 2, pp. 255–260, 2003. View at: Publisher Site | Google Scholar
  32. B. Machura, R. Kruszynski, M. Jaworska, J. Kłak, and J. Mroziński, “Synthesis, crystal, molecular and electronic structure of [ReOCl3(phen)] and [ReCl2(phen)(PPh3)2](ReO4) complexes,” Polyhedron, vol. 25, no. 13, pp. 2537–2549, 2006. View at: Publisher Site | Google Scholar
  33. H. Mao, Z. Deng, F. Wang, T. M. Harris, and M. P. Stone, “An intercalated and thermally stable FAPY adduct of aflatoxin B1 in a DNA duplex: structural refinement from 1H NMR,” Biochemistry, vol. 37, no. 13, pp. 4374–4387, 1998. View at: Publisher Site | Google Scholar
  34. P. K. Ganguli and T. Theophanides, “Premelting phenomenon in DNA caused by the antitumor drug cis-dichlorodiammineplatinum,” Inorganica Chimica Acta, vol. 55, pp. L43–L45, 1981. View at: Google Scholar
  35. P. J. Cox, G. Psomas, and C. A. Bolos, “Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2],” Bioorganic and Medicinal Chemistry, vol. 17, no. 16, pp. 6054–6062, 2009. View at: Publisher Site | Google Scholar
  36. D. Lawrence, V. G. Vaidyanathan, and B. U. Nair, “Synthesis, characterization and DNA binding studies of two mixed ligand complexes of ruthenium(II),” Journal of Inorganic Biochemistry, vol. 100, no. 7, pp. 1244–1251, 2006. View at: Publisher Site | Google Scholar
  37. D.-L. Ma, C.-M. Che, F.-M. Siu, M. Yang, and K.-Y. Wong, “DNA binding and cytotoxicity of ruthenium(II) and rhenium(I) complexes of 2-amino-4-phenylamino-6-(2-pyridyl)-1,3,5-triazine,” Inorganic Chemistry, vol. 46, no. 3, pp. 740–749, 2007. View at: Publisher Site | Google Scholar
  38. V. Rajendiran, M. Murali, E. Suresh, S. Sinha, K. Somasundaram, and M. Palaniandavar, “Mixed ligand ruthenium(ii) complexes of bis(pyrid-2-yl)-/bis(benzimidazol- 2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity,” Dalton Transactions, no. 1, pp. 148–163, 2008. View at: Publisher Site | Google Scholar
  39. V. W.-W. Yam, K. K.-W. Lo, K.-K. Cheung, and R. Y.-C. Kong, “Deoxyribonucleic acid binding and photocleavage studies of rhenium(I) dipyridophenazine complexes,” Dalton Transactions, no. 12, pp. 2067–2072, 1997. View at: Google Scholar
  40. H. D. Stoeffler, N. B. Thornton, S. L. Temkin, and K. S. Schanze, “Unusual photophysics of a rhenium(I) dipyridophenazine complex in homogenous solution and bound to DNA,” Journal of the American Chemical Society, vol. 117, no. 27, pp. 7119–7128, 1995. View at: Google Scholar

Copyright © 2010 Christiana A. Mitsopoulou and Constantinos Dagas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1568
Downloads844
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.